Romilda Cardin
Overview
Explore the profile of Romilda Cardin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
897
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campello E, Zanetto A, Prokopenko Y, Ilich A, Moonla C, Bulato C, et al.
Thromb Haemost
. 2024 Dec;
PMID: 39719151
Background: Portal vein system-specific risk factors contributing to portal vein thrombosis in cirrhosis are poorly investigated. Aim: This study aimed to quantify contact system and intrinsic pathway activation in the...
2.
Facchin S, Cardin R, Patuzzi I, Carlotto C, Minotto M, Barberio B, et al.
Dig Liver Dis
. 2024 Dec;
57(3):702-706.
PMID: 39672770
Background: Freezing donor fecal microbiota has improved fecal microbiota transplantation (FMT) for recurrent C. difficile infection (CDI), achieving short-term effectiveness similar to fresh-samples. Research shows frozen fecal matter remains effective...
3.
Pelizzaro F, Cardin R, Sarasini G, Minotto M, Carlotto C, Fassan M, et al.
Inflamm Intest Dis
. 2024 Feb;
9(1):11-21.
PMID: 38298886
MicroRNAs (miRNAs) are small, non-coding RNA molecules involved in regulating gene expression. Many studies, mostly conducted on pediatric patients, suggested that oxidative stress and several miRNAs may play an important...
4.
Pinto E, Pelizzaro F, Cardin R, Battistel M, Palano G, Bertellini F, et al.
Dig Liver Dis
. 2023 Oct;
56(5):872-879.
PMID: 37783655
Background: Neoangiogenesis plays a crucial role in the progression of hepatocellular carcinoma (HCC), and concerns have been raised about the role of neoangiogenesis on the effectiveness of transarterial chemoembolization (TACE)....
5.
Zingone F, Pilotto V, Cardin R, Maddalo G, Orlando C, Fassan M, et al.
Front Immunol
. 2022 Aug;
13:930989.
PMID: 35941891
Introduction: MicroRNAs (miRNAs) have been proposed as diagnostic markers, biomarkers of neoplastic progression, and possible therapeutic targets in several immune-mediated diseases. We aimed to analyze the expression profile of selected...
6.
Pelizzaro F, Cardin R, Sartori A, Imondi A, Penzo B, Aliberti C, et al.
Biomedicines
. 2021 Aug;
9(8).
PMID: 34440094
Background: MicroRNAs (miRNAs) have been proposed as biomarkers in hepatocellular carcinoma (HCC). We aim at evaluating miR-21 and miR-122 in HCC patients treated with drug-eluting beads transarterial chemoembolization (DEB-TACE) as...
7.
Massimi D, Barberio B, Bertani L, Costa F, Ferronato A, Facchin S, et al.
Therap Adv Gastroenterol
. 2021 Jul;
14:17562848211023384.
PMID: 34249147
Background: Current literature still lacks studies evaluating the effectiveness and safety of switching from Infliximab originator to SB2 biosimilar in Inflammatory Bowel Diseases (IBDs). We aimed to verify the ability...
8.
Pelizzaro F, Cardin R, Penzo B, Pinto E, Vitale A, Cillo U, et al.
Cancers (Basel)
. 2021 Jun;
13(9).
PMID: 34068786
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer related death worldwide. Diagnostic, prognostic, and predictive biomarkers are urgently needed in order to improve patient survival. Indeed, the...
9.
Facchin S, Buda A, Cardin R, Agbariah N, Zingone F, De Bona M, et al.
Therap Adv Gastroenterol
. 2021 Apr;
14:1756284821999902.
PMID: 33815569
Anti-drug antibodies can interfere with the activity of anti-tumor necrosis factor (TNF) agents by increasing drug clearance direct neutralization. The presence of anti-drug antibodies is clinically relevant when trough drug...
10.
Pelizzaro F, Kitenge M, Cardin R, Ponzoni A, Cillo U, Vitale A, et al.
Clin Exp Med
. 2021 Mar;
21(4):675-682.
PMID: 33768340
We aimed to explore the activation of monoacylglycerol lipase (MAGL)/cyclooxygenase-2 (COX-2)/prostaglandin E (PGE2) axis in hepatocellular carcinoma (HCC), evaluating circulating PGE2 as prognostic biomarker in HCC patients. PGE2 levels were...